Revive Therapeutics in Agreement With Defence Research and Development Canada to Evaluate Bucillamine for Nerve Agent Exposure
Revive Therapeutics in Agreement With Defence Research and Development Canada to Evaluate Bucillamine for Nerve Agent Exposure
Revive Therapeutics與加拿大國防研究與發展部達成協議,評估布西拉明對神經毒劑暴露的影響
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊